SIMFER guidelines on physical modalities for chronic primary pain management.
Giovanni Iolascon, Matteo Franchi, Andrea Bernetti and 14 others
PMID 42262745WHAT IT FOUND
The panel suggests adding physical modalities such as TENS, laser or cryotherapy to conventional treatment for fibromyalgia and complex regional pain syndrome, never using them alone.
The supporting evidence is low certainty, but side effects were mild and transient.
Key findings
01The Italian guideline panel made a conditional recommendation in favour of using instrumental physical therapies in addition to conventional therapy, and rated the overall certainty of the evidence as low, ranging from moderate to very low.
02How large the reported effects are does not track how confident the panel was in them. TENS had moderate-certainty pain reduction and high-certainty disability improvement in fibromyalgia, while cryotherapy (-1.17 pain, -2.05 disability), whole-body vibration (-1.60 and -1.54), laser (-1.67 and -1.62) and NMES (-3.91 and -1.32) were reported as large but came from low or very low certainty evidence, and pulsed electromagnetic fields produced a change the paper itself calls not clinically relevant in fibromyalgia (-0.19).
03Undesirable effects of these therapies were trivial or mild and transient, most studies reported no adverse events, and no serious adverse events were described, though the certainty of this evidence was low because only some studies systematically reported harms.
STILL TO COME
How it was doneWhat they foundWhat it means for PTs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The panel itself judged the overall certainty of the evidence to be low, ranging from moderate to very low, because of imprecise estimates, risk of bias including performance, detection and attrition bias, and inconsistency between studies. Several of the largest reported effects, for whole-body vibration, cryotherapy and NMES, come from single small or high-risk-of-bias studies, so those numbers could easily be wrong in either direction. No studies at all were found for primary bone marrow oedema syndromes, which was one of the three conditions the guideline set out to answer for. No cost-effectiveness studies were identified. Costs were estimated from Italian national reimbursement tariffs, and the searches for feasibility and equity studies returned nothing eligible. Data on patient values and preferences came from a single study, and none existed for people with CRPS. Documented adverse events were based on only a subset of studies that systematically reported them. The recommendation is conditional rather than strong, and it is written for the Italian healthcare system, so access and cost implications may not transfer elsewhere.
Declared interests
The authors state they received no external funding for the guideline. Two panel members declared interests: Matteo Franchi reported research support relating to reimbursement for attending conferences or educational activities, and Alessandro Picelli reported research funding from organisations with commercial interests related to the guideline topic. The panel states that members abstained from voting on the strength of recommendations where they had authored included studies or had received direct or indirect funding from companies connected to the intervention under evaluation, and the remaining authors declared no competing interests.
The easy way to misread this
Do not take the recommendation as proof these therapies work. The panel itself rated the overall certainty of the evidence as low, and the eye-catching effect sizes for whole-body vibration, cryotherapy and NMES come from a few small or high-risk-of-bias studies. Treat them as add-ons to exercise, education and psychological support, not as replacements for them.
Summarised by AI from the full paper, without a clinician reviewing it. Check it against the source before it changes what you do. Read it on PubMed →